» Articles » PMID: 35836031

Prevalence and Treatment of Fragility Fractures in Spanish Primary Care: PREFRAOS Study

Overview
Journal Arch Osteoporos
Publisher Springer
Date 2022 Jul 14
PMID 35836031
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In Spanish PC, the prevalence of FF is high, especially in women. One-third of subjects with a FF lacked an OP diagnosis and more than half were not currently receiving OP medication. Several studies reported underdiagnosis/undertreatment of OP in PC among elderly subjects with FF. To date, no such data exist for Spain. The purpose is to estimate the prevalence of FF in the elderly population (≥ 70 years old) and to describe the characteristics, risk factors, comorbidities, and OP diagnosis and treatment rates of subjects with FF in Spanish PC centers.

Methods: This is an observational, retrospective study in Spain consisting of two phases. Phase A included all subjects ≥ 70 years old listed in the center's medical records from November 2018 to March 2020. Phase B included subjects with FF and prior consultation at the center for any reason. Subjects were excluded only if they had previously participated in another study. Primary outcomes were prevalence of FF (phase A) and characteristics of subjects with at least one FF (phase B).

Results: The overall prevalence of FF was 17.7% among subjects visiting medical centers for any reason (24.1% women vs. 8.0% men) (30 PC centers from 14 Spanish regions). Vertebral (5.1%) was the most prevalent fracture. Of 665 subjects in phase B, most (87%) were women and ≥ 80 years old (57%), suffered mainly major OP fracture (68%), and had multiple comorbidities (≥ 2, 89.2%). While two-thirds had OP diagnosis and 61.1% received OP medication anytime in the past, 56.8% were not currently receiving OP medication. Diagnosis and treatment rates were lower among men (43% and 38% vs. 70% and 65%, respectively).

Conclusion: Prevalence of FF was high, especially in women. One-third of subjects lacked OP diagnosis and ≥ 50% were not receiving OP treatment; diagnosis and treatment gaps were larger among men. This reinforces the need to improve the management of FF in the elderly population. However, as PC centers participating in this study had high OP experience that have the potential to do better in terms of diagnosis and treatment, caution in the generalization of these data should be taken.

Citing Articles

Real-World Osteoporosis Treatment Gap and Costs in Spain: Data from Women with a First Fragility Fracture or Diagnosis of Postmenopausal Osteoporosis.

Sicras-Mainar A, Sorio-Vilela F, Sacrest-Soy M, Gatell S, Sicras-Navarro A, Villoro-Valdes R Rheumatol Ther. 2025; .

PMID: 39932674 DOI: 10.1007/s40744-024-00743-5.


Secondary fracture prevention in Spanish primary care: results of the PREFRAOS Study.

Martinez-Laguna D, Carbonell Abella C, Bastida J, Gonzalez M, Mico-Perez R, Vargas F Arch Osteoporos. 2024; 19(1):35.

PMID: 38722400 PMC: 11081989. DOI: 10.1007/s11657-024-01394-3.


Management of Vertebral Fragility Fracture in Older People: Recommendations from a Spanish Consensus of Experts.

Castaneda S, Navarro Ceballos C, Uson Jaeger J, de Miguel Benadiba C, Gomez Martin E, Diaz-Guerra G Geriatrics (Basel). 2024; 9(2).

PMID: 38525741 PMC: 10961758. DOI: 10.3390/geriatrics9020024.


Integrating post-fracture care into the primary care setting (interFRACT): Protocol for a mixed-methods study to co-design a care program to improve rates of osteoporosis and fracture treatment.

Talevski J, Beauchamp A, Bird S, Daly R BMJ Open. 2023; 13(4):e067560.

PMID: 37076158 PMC: 10124312. DOI: 10.1136/bmjopen-2022-067560.

References
1.
Harvey N, McCloskey E, Mitchell P, Dawson-Hughes B, Pierroz D, Reginster J . Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. 2017; 28(5):1507-1529. PMC: 5392413. DOI: 10.1007/s00198-016-3894-y. View

2.
Kanis J, Johnell O, Oden A, Sembo I, Redlund-Johnell I, Dawson A . Long-term risk of osteoporotic fracture in Malmö. Osteoporos Int. 2000; 11(8):669-74. DOI: 10.1007/s001980070064. View

3.
Kanis J, McCloskey E, Johansson H, Cooper C, Rizzoli R, Reginster J . European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2012; 24(1):23-57. PMC: 3587294. DOI: 10.1007/s00198-012-2074-y. View

4.
Azagra R, Zwart M, Encabo G, Aguye A, Martin-Sanchez J, Puchol-Ruiz N . Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women. BMC Musculoskelet Disord. 2016; 17:262. PMC: 4912785. DOI: 10.1186/s12891-016-1096-6. View

5.
Miller P . Underdiagnosis and Undertreatment of Osteoporosis: The Battle to Be Won. J Clin Endocrinol Metab. 2016; 101(3):852-9. DOI: 10.1210/jc.2015-3156. View